Biotech Values

[genisi]

Using GS9350 rather than Ritonavir will allow GILD to have all the rights to a single once-daily treatment for HIV, with potentially a smaller pill size (GS9350 will replace 100mg Ritonavir), and a new PK enhancer which is devoid of HIV activity.